Drug Trial Radar · NCT07584967
A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Nov 15, 2026
Primary completion
Jul 30, 2028
Study completion Aug 30, 2028
Sponsor
- Lead sponsor
- AnaCardio ABIndustry
- Sponsor type
- Industry
- First posted
- May 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate the safety and efficacy of 2 doses of AC01 compared to placebo over 12 weeks in participants with chronic advanced HFrEF.
Conditions
- Heart Failure With Reduced Ejection Fraction (HFrEF)
Interventions
AC01Drug
AC01 tablets for oral administration.
PlaceboOther
AC01 matching placebo tablets for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change from Baseline in Composite Echocardiography Z-Score at Week 12Time frame: Baseline and Week 12
Locations
14 sites in 8 countries. Site status is shown where the registry gives one.
Progressive MD, InvivoCure
Van Nuys, California · Recruiting
Nature Coast Clinical Research
Crystal River, Florida · Recruiting
Chicago Cardiology Institute
Schaumburg, Illinois · Recruiting
Capital Area Research, LLC - Camp Hill
Camp Hill, Pennsylvania · Recruiting
Multi-Profile Hospital for Active Treatment (MHAT) - Hospital Puls
Blagoevgrad, Bulgaria · Recruiting
Medical Center I - Burgas
Burgas, Bulgaria · Recruiting
Medical Center Medconsult Pleven
Pleven, Bulgaria · Recruiting
Diex Recherche Trois-Rivières
Trois-Rivières, Canada · Recruiting
Diex Recherche Sherbrooke
Sherbrooke, Québec (QC), Canada · Recruiting
Kardio Michal Čepelák, s.r.o.
Klatovy, Czechia · Recruiting
Medicome Sp z o.o. Oswiecimskie Centrum Medyczne
Oświęcim, Poland · Recruiting
MUDr. Daniela Viňanská Interná a kardiologická ambulancia, Medispol, s.r.o
Prešov, Slovakia · Recruiting
Hospital SON LLATZER
Palma, Spain · Recruiting
Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.